Abemaciclib additionally capivasertib versus placebo after backslide or perhaps progression while on an aromatase chemical within metastatic, excess estrogen receptor-positive cancers of the breast (FAKTION): a multicentre, randomised, manipulated, phase 2 trial. Website: http://en.wikipedia.org/wiki/Carmofur